No tumor cells were found in surgical specimens of nearly 1/4 patients. The world's first IO
The first show of Guangdong Congress (Part 1): True and false CR after ALK-positive lung adenocarcinoma targeted therapy
"Self-delivery" RNAi therapy targeting PD-1 has powerful tumor control and tumor microenvironment regulation capabilities | Yimai Meng broke the news
In 2020, 1 billion treprisumab was sold, and the third indication was "taken" in China
Subcutaneous RNAi therapy ALN-AGT Phase 1 clinical trial results are positive
The second domestic company, Junshi PD-1 urothelial carcinoma was approved for listing by NMPA
A 69-year-old man has repeatedly vomited blood for 1 week, but he was blocked by a stone?
Kelun Class 1 new drug hits 2 billion injections, the first four major products that have been reviewed and will be approved
1 billion, Medtronic announces important news
Irritable bowel syndrome, these 4 new drugs deserve attention in 2021
4 stroke cases, analyze the details of the major guides, worthy of collection
Beida Pharmaceutical's Class 1 new anti-cancer drug BPI-421286 was approved for clinical use
Xinjiang’s “2+4” Drug Purchasing Alliance Came to Promote Inter-provincial Centralized Procurement
New medicine for the treatment of type 1 diabetes-TTP399 efficacy and safety results announced!
The putty layer is 4 mm thick, which is strange if there is no problem with this kind of wall surface!
1 minute self-test, 5 small questions about the diagnosis and treatment of diabetic nephropathy (1) | Clear the "Secret" language
The Johnson & Johnson vaccine caused 4 cases of blood clots. Is the adenovirus vector vaccine still safe?
Junshi PD-1 urothelial cancer indication is officially approved
Express | Blockbuster PD-1 inhibitors in the treatment of early stage lung cancer reach the phase 3
FIB-4 Index: It can predict the risk of liver cancer in patients with chronic hepatitis B after antiviral treatment